NCT01714466View on ClinicalTrials.gov

Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening Colonoscopy

PHASE2CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

January 31, 2014

Conditions
Colon Cancer
Interventions
DRUG

NER1006

DRUG

MOVIPREP

Trial Locations (2)

14050

PAREXEL International Early Product Development Unit, Berlin

Parexel International GmbH, Berlin

Sponsors

Lead Sponsor

Norgine
All Listed Sponsors
lead

Norgine

INDUSTRY

NCT01714466 - Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening Colonoscopy | Biotech Hunter | Biotech Hunter